Performance Assessment of First-Generation Anti-SARS-CoV-2 Serological Assays
Mehjabeen Imam, Shabnum Khawaja, Arshi Naz, Ahson Siddiqui, Tehmina S. Nafees, Amber Younus, Usama Shamsi, Imran Shabir, Shakir Ahmed, Naveen Tariq, Salman Tariq, Tahir S. Shamsi
doi: https://doi.org/10.1101/2020.09.22.20197046
Mehjabeen Imam
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Shabnum Khawaja
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Arshi Naz
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Ahson Siddiqui
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Tehmina S. Nafees
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Amber Younus
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Usama Shamsi
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Imran Shabir
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Shakir Ahmed
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Naveen Tariq
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Salman Tariq
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Tahir S. Shamsi
National Institute of Blood Disease and Bone Marrow Transplantation (NIBD), Karachi, Pakistan
Data Availability
There is no external material online or any external datasets are used in this manuscript. This is a single center study. Manuscript has original content.
Posted September 24, 2020.
Performance Assessment of First-Generation Anti-SARS-CoV-2 Serological Assays
Mehjabeen Imam, Shabnum Khawaja, Arshi Naz, Ahson Siddiqui, Tehmina S. Nafees, Amber Younus, Usama Shamsi, Imran Shabir, Shakir Ahmed, Naveen Tariq, Salman Tariq, Tahir S. Shamsi
medRxiv 2020.09.22.20197046; doi: https://doi.org/10.1101/2020.09.22.20197046
Performance Assessment of First-Generation Anti-SARS-CoV-2 Serological Assays
Mehjabeen Imam, Shabnum Khawaja, Arshi Naz, Ahson Siddiqui, Tehmina S. Nafees, Amber Younus, Usama Shamsi, Imran Shabir, Shakir Ahmed, Naveen Tariq, Salman Tariq, Tahir S. Shamsi
medRxiv 2020.09.22.20197046; doi: https://doi.org/10.1101/2020.09.22.20197046
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2972)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12821)
- Forensic Medicine (12)
- Gastroenterology (833)
- Genetic and Genomic Medicine (4625)
- Geriatric Medicine (424)
- Health Economics (733)
- Health Informatics (2944)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4417)
- Nursing (238)
- Nutrition (653)
- Oncology (2298)
- Ophthalmology (653)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (503)
- Public and Global Health (7011)
- Radiology and Imaging (1549)
- Respiratory Medicine (922)
- Rheumatology (446)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)